
Cilastatin: a potential treatment strategy against COVID-19.
noviembre 1, 2020 DOI: 10.1093/ckj/sfaa193
María Ángeles González-Nicolás, Cristian González-Guerrero, Verónica Astrid Pérez-Fernández, Alberto Lázaro. Clinical Kidney Journal, Volume 13, Issue 5, October 2020, Pages 903–905. DOI: 10.1093/ckj/sfaa193 Based on the preclinical evidence of kidney and lung protection in the context of endotoxemia as presented in this letter. We propose that cilastatin should be studied in clinical trials as a potential therapy for COVID-19.… Leer más »Cilastatin: a potential treatment strategy against COVID-19.